RNU6-256P

Across TCGA pan-cancer cohorts, RNU6-256P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-256P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-256P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-256P expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

LIHC, UCS, and BRCA are the cancer types where RNU6-256P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.041	0.781	<.001	108	view →
UCS	DFS	Tertile	III,IV	1.000	0.156	.001	78	view →
BRCA	DFS	Tertile	All	0.321	0.903	<.001	36	view →
KIRC	DFS	Tertile	All	0.260	0.796	.012	36	view →
LUAD	OS	Tertile	All	0.035	0.812	<.001	36	view →
OV	OS	Tertile	II,III,IV	0.628	0.845	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-256P–LIHC (OS)

Open the LIHC breakdown →